EGFR and cancer: The evidence for the connection between ErbB family members and different forms of cancer, accumulated over the years, led to the development of different agents for the inhibition of EGFR as anti-cancer drugs (Cancer Genome Atlas Network, 2012; Lemmon et al., 2014).